OUR STORY

Somerset is built around the belief that disciplined capital can drive both performance and meaningful healthcare impact. Focused on India’s healthcare “Missing Middle,” the firm invests in scalable healthcare platforms that improve access, affordability, and quality across underserved markets. With a strong foundation in healthcare and life sciences, Somerset combines long-term partnerships, operational value creation, and institutional discipline to build resilient businesses with purpose-driven growth.

MISSION
To partner with healthcare entrepreneurs across India’s tier II and tier III markets, providing strategic capital and operational expertise to increase healthcare availability, accessibility, and affordability while delivering quality care to both underserved and privileged populations, also leveraging technology as a catalyst for sustainable healthcare transformation.
VISION
To become the leading strategic, operational, and financial partner in India’s healthcare sector, enabling growth at scale in underserved tier II and tier III markets.

Foundational Pillars

Somerset operates on three core pillars that anchor our investment philosophy, governance standards, and long-term approach to value creation.

Institutional Team and Best Practices

Institutionalisation is an ongoing priority as Somerset scales. We continue to deepen structured governance frameworks, SOP-led processes, risk oversight, and functional capabilities to support disciplined decision-making and long-term platform scalability. As the firm evolves, institutional rigour remains central to how we invest, operate, and partner.

Philosophy, Value Creation, and Performance

Strong returns are built on rigorous underwriting, active value creation, and disciplined capital allocation. Our track record reflects a focus on downside protection, operational engagement, and long-term performance consistency.

ESG and
Impact Leadership

Responsible investing is embedded within our process. Our SDG-aligned framework integrates impact measurement and ESG integration across access, affordability, jobs, and quality. This approach supports sustainability-aligned investing with measurable and transparent outcomes.

Capital for change in healthcare

2011

A Conviction Takes Shape

Founded by Avinash Kenkare and Mayur Sirdesai, Somerset brought together global private equity experience with deep sector expertise in healthcare and life sciences.

From the outset, the focus was clear—India’s “Missing Middle”: underserved, underpenetrated markets beyond metros with strong potential for scalable healthcare platforms.

2012

Fund I

Somerset Indus Healthcare Fund I achieved its first close on 1 January 2012, marking the beginning of Somerset’s platform-building journey across healthcare delivery, pharma, diagnostics, MedTech, and wellness.

Building the Lens | Focus & Discipline

Somerset focused early on Tier II and Tier III India, where access gaps were widest.

A disciplined investment approach, long-term partnerships, and active value creation became core to the model—driving both performance and measurable outcomes in access, affordability, and quality.

2018–2019

Fund II & Institutionalisation

With the launch of Fund II

  • Offshore Fund: 6 June 2018
  • Onshore Fund: 30 April 2019

Somerset deepened its leadership with the addition of Partners- Ramesh Kannan and Sharad Ladha.

ESG Formalised
Responsible investing became institutionalised, with ESG frameworks embedded across the investment lifecycle—strengthening governance, risk management, and long-term value creation.

Evolving the Model | Capital as Catalyst

Somerset’s approach evolved beyond capital deployment to active partnership. Early promoter engagement, operational value creation, and institutional discipline enabled scalable, resilient healthcare platforms.

2024

Fund III & Impact Integration

Fund III achieved its first close on 12 August 2024, continuing Somerset’s focus on catalytic growth capital for healthcare platforms serving India’s Missing Middle.

Impact Formalised
A dedicated Impact function was established—bringing structured measurement, reporting, and alignment with global impact frameworks.

FY2025

Strengthening the Platform

  • Memberships with GIIN and Impact Investors Council (IIC)
  • Enhanced alignment with global impact standards and best practices


Today | Performance with Purpose

Somerset continues to build scaled healthcare platforms that deliver strong returns while improving access, affordability, and quality.

A consistent strategy. A clear purpose.

Investment Criteria

We invest in healthcare that improves outcomes and scales what works
Cheque Size
USD 15-40 Mn
Investment Stage
Growth
Revenue Threshold
INR 500 Mn
EBITDA Threshhold
Profitable / Path to Profitability
Geographies Served
Pan India

Somerset’s Sector Focus

Driving investment into scalable platforms that enhance healthcare access and outcomes across India.
Healthcare Delivery

Hospitals and specialty clinics in Tier 2 and Tier 3 India – the backbone of the Missing Middle thesis.

We back multi-specialty and single-speciality platforms with the capital and operational support to scale beyond metros.

Backbone of the Missing Middle

Diagnostics

Pathology, radiology, and PPP-enabled diagnostic networks that bring affordable, quality testing closer to underserved populations.

Bringing quality diagnostics closer

Pharmaceuticals & Life Sciences

CDMOs, APIs, branded generics, and biosimilars.

India is the pharmacy of the world – we back the mid-sized operators building that supply chain from the inside out.

Powering India, Supplying the World

Medtech & Medical Devices

From biomedical equipment distribution to frugal innovation designed for Indian clinical environments.

The right device in the right hospital in the right city changes outcomes.

Right device. Right impact.

Retail Chains & Distribution

Pharma retail chains, cold chain infrastructure, stockist distribution, and supply chain networks that ensure availability, affordability, and last-mile reach across India.

Right product. Right place. Every time

Wellness & Nutrition

Nutraceuticals, clinical nutrition, and preventive health – a sector that has moved from discretionary to essential as India’s disease burden shifts toward chronic lifestyle conditions.

From Discretionary to Essential

Healthtech & Digital Health

Telemedicine, AI-enabled diagnostics, and digital health platforms are compressing the distance between patient and provider.

We back technology that solves real access problems.

Technology with Purpose.

Healthcare Financing & Insurance

Micro-insurance, health BNPL, and insurance models designed for the Missing Middle.

Affordable care means nothing if the financing isn’t there to access it.

Access enabled. Care delivered.

Allied Healthcare

An integrated ecosystem that includes diagnostics support, physiotherapy, rehabilitation, home care, mental health, and more.

Also includes animal health and elderly care services – addressing critical and underserved needs across the care continuum.

Integrated care. Better outcomes.

Healthcare Packaging

An underappreciated but critical link in the pharmaceutical supply chain – sustainable, compliant packaging that supports India’s growing pharma export ambitions.

Sustainable. Compliant. Future-ready.

Structural Drivers of
Healthcare Growth

Rising Healthcare Spending

Growing incomes, increasing health awareness, and expanding middle-class consumption are accelerating healthcare spending across services, diagnostics, and wellness.

Insurance Expansion & Government Support

Large-scale programs such as Ayushman Bharat, along with increasing private insurance penetration, are expanding access to healthcare services across the country.

Changing Disease Burden

India is witnessing a shift from infectious diseases toward chronic and lifestyle-related illnesses, driving sustained demand for hospitals, diagnostics, and specialty care.

Technology & Digital Health Adoption

Telemedicine, AI-enabled diagnostics, digital health platforms, and advanced medical technologies are improving healthcare delivery and accessibility.

WHERE WE INVEST?

We focus on businesses with:
  • Strong financial fundamentals and scalable, defensible business models
  • Investment sizes of $15 to $40 million
  • Measurable impact outcomes supported by responsible business practices
  • Proven promoters with execution strength and adaptability
  • Clear and time-bound exit pathways via IPO, strategic sale, or secondary transactions

WHERE WE INVEST?

Why Now?

Scale Meets Structural Gaps

India is one of the fastest-growing major economies globally, yet a meaningful gap persists between economic progress and access to essential services.

  • 7%+ GDP Growth 
  • 1.4B+ Population 
  • $1T+ FDI Inflows 

 

Rising incomes and rapid urbanisation are accelerating demand—creating large, underpenetrated opportunity pools.

Where the Gap is Most Visible

This disconnect is most pronounced in healthcare, where demand is strong, but infrastructure and delivery remain constrained.

WHY NOW?

Healthcare

High Demand. Structural Undersupply.

India’s healthcare sector is defined by strong demand fundamentals but limited organized capacity:

Access & Infrastructure Gap

  • ~1.3-1.5 beds per 1,000 people 
  • Below 2 beds per 1,000 target (policy benchmark) 
  • Significant regional disparities in access 


Low Spend, High Out-of-Pocket

  • ~3.2% of GDP healthcare spend 
  • ~48–60% out-of-pocket expenditure 


Rising Demand Drivers

  • 500M+ people covered under public health insurance (Ayushman Bharat) 
  • Shift toward chronic and lifestyle diseases 
  • Rapid adoption of digital health and telemedicine 


Demand is scaling rapidly—but supply remains fragmented and capacity-constrained.

The Resulting Opportunity

This persistent gap between demand and delivery creates a large, scalable investment opportunity across hospitals, diagnostics, and tech-enabled care.

Healthcare

Growth Capital

The Catalyst for Scale and Consolidation

India’s healthcare ecosystem is rich in high-quality operators—but constrained by fragmentation and limited access to capital.

Fragmented Market

  • Private sector delivers ~70%+ of care 
  • Highly regional, sub-scale providers dominate 


Capacity Shortfall

  • ~3M additional beds required to meet demand 
  • Shortage of doctors, nurses, and infrastructure 


Capital Gap

  • Majority of providers remain: 
    • Promoter-led 
    • Regionally concentrated 
    • Under-institutionalised 


What Growth Capital Enables

  • Expansion of beds, labs, and infrastructure 
  • Consolidation of fragmented assets 
  • Integration of digital and AI-led solutions 
  • Institutionalisation of scalable platforms

Growth Capital

The Opportunity

India × Healthcare × Growth Capital

  • India → Large, underpenetrated market 
  • Healthcare → Structural demand with supply gaps 
  • Growth Capital → Enables scale, consolidation, and efficiency 


This convergence points to a meaningful opportunity to address critical healthcare gaps across India.

India at a Glance (Layout: Statistics Cards)

7.4%
Projected real GDP growth for FY26, positioning India among the fastest-growing major economies.

US$1.12 Trillion
Cumulative FDI inflows since 2000, reflecting strong global investor confidence.

1.4+ Billion
Population with one of the world’s youngest demographic profiles and rising healthcare demand.

Rapid Urbanisation & Rising Incomes
Driving increased healthcare consumption and private sector participation.

The Opportunity

Differentiators

Value Creation

Somerset partners with proven operators building scalable healthcare platforms in India’s underserved Tier II and III markets. Our approach is hands-on from day one – we engage early with promoters, often before capital is deployed, to align on strategy, strengthen leadership, and build the institutional foundations that enable sustainable scale.

We don’t just provide capital. We co-build – structuring 100-Day Plans post-investment, supporting critical management hires, enabling inorganic expansion through M&A, opening market access channels, and embedding ESG and Impact discipline across operations. Every lever we pull is oriented toward one outcome: a healthcare business that is larger, stronger, and more resilient at exit than it was at entry.

Strategy & Commercial Model

Strategy & Commercial Model

Helping promoters sharpen their market positioning, drive cost optimisation, and define growth strategies across Tier I, II, and III markets in India. Capital raises and Next growth capital cycle- Supporting capital raises and the next growth cycle by shaping strategy, connecting with the right partners aligned to that strategy, and driving disciplined negotiations.

Capacity Building, Talent & Leadership

Capacity Building, Talent & Leadership

Identifying and onboarding CXOs, functional heads, and independent directors who institutionalise the business and prepare it for the next phase of scale.

Governance & Systems

Governance & Systems

Implementing MIS, audit functions, compliance frameworks, board-level oversight, technology systems and robust processes that de-risk the business and attract co-investors and acquirers.

Inorganic Growth

Inorganic Growth

Identifying M&A targets, facilitating acquisitions, and supporting post-merger integration to accelerate platform building.

Market & Network Access

Market & Network Access

Leveraging Somerset's relationships with government agencies, global partners, DFIs, external specialists and sector expert networks to open cross-border and domestic doors that capital alone cannot.

Inter-portfolio synergies

Inter-portfolio synergies

Our healthcare focus allows portfolio companies to collaborate, share best practices, and unlock cross-platform partnerships and efficiencies.

ESG & Impact

ESG & Impact

Embedding measurable impact targets, ESG reporting, and SDG-aligned frameworks that strengthen the business operationally and position it for DFI and institutional capital.

Differentiators

One sector-Full conviction.

Every investment Somerset makes is in India's healthcare ecosystem. This is not a theme allocation - it is our entire focus. That depth of sector specialisation gives us an edge in sourcing, underwriting, and value creation that no generalist fund can replicate.

We back operators, not just opportunities.

The Missing Middle is not short of healthcare businesses. It is short of capital backing the right people to build them. We invest in promoters with execution strength, governance orientation, and the resilience to build institutions that outlast market cycles. Our conviction starts with the builder.

Hands-on, not hands-off.

100+ years of combined experience across healthcare, life sciences, and private equity - deployed actively inside our portfolio companies. We sit on boards, hire leadership, support M&A, and engage operationally from investment to exit. Our value creation is not advisory. It is on-the-ground.

ESG and Impact embedded, not bolted on.

Impact measurement, ESG screening, and SDG alignment are integrated into every stage of our investment process - from deal evaluation through to exit.

First cheque. First institutional partner.

For many of the founders we back, Somerset is the first institutional capital they receive. We come in early and stay close - bringing governance, operational support, R&D capabilities and network access from the very start.

A track record that holds up.

Fund I: 4.6x Gross MOIC, ~4x DPI, zero loss ratio. Three funds. Thirteen years. ~$400M AUM

Investing in India's Missing Middle.

Tier I, II and III India- Missing Middle represents the largest unmet healthcare opportunity in the country - and it has been Somerset's primary focus since inception. We have spent that time building relationships, sourcing deals and creating value in markets that are structurally underserved and capital starved. We understand how healthcare businesses operate in urban and rural centres - the demand patterns, the constraints and the opportunities.